Novo Nordisk v. Caraco Pharmaceutical Laboratories
Novo Nordisk v. Caraco Pharmaceutical Laboratories
Opinion
NOTE: This order is nonprecedential.
Wniteb ~tates ([ourt of ~peals for tbe jfeberal ([ircuit
NOVO NORDISK AlS AND NOVO NORDISK INC., Plaintiffs-Appellants, v. CARACO PHARMACEUTICAL LABORATORIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellees.
2011-1223
Appeal from the United States District Court for the Eastern District of Michigan in case no. 05-CV-40188, Judge Avern Cohn.
ON MOTION
ORDER The parties jointly move to stay the briefing schedule, pending the Supreme Court's disposition of Caraco Phar- maceutical Laboratories, Ltd. v. Novo Nordisk AI S, No. 10-844. The Supreme Court granted certiorari in Caraco on June 27, 2011. NOVO NORDISK v. CARACO PHARMA 2 Upon consideration thereof, IT Is ORDERED THAT: The motion is granted. The parties are directed to in- form this court, within 14 days of the Supreme Court's disposition of Caraeo, concerning how they believe this appeal should proceed. FOR THE COURT
JUL 212011 lsI Jan Horbaly Date Jan Horbaly Clerk cc: Mark A. Perry, Esq. James F. Hurst, Esq. s20 FILED '.s.THE FEDERAL CIRCUITFOR COORT OF APPEALS
JUL 27 2011 JAN HORBALY CLERK
Reference
- Status
- Unpublished